Alvarez J, Jafri M, Ullah A
Biomolecules. 2024; 14(11).
PMID: 39595549
PMC: 11591732.
DOI: 10.3390/biom14111371.
Dhalla N, Mota K, de Vasconcelos C, Adameova A
Int J Mol Sci. 2024; 25(5).
PMID: 38473855
PMC: 10931943.
DOI: 10.3390/ijms25052610.
Gonnot F, Boulogne L, Brun C, Dia M, Gouriou Y, Bidaux G
Nat Commun. 2023; 14(1):3346.
PMID: 37291092
PMC: 10250397.
DOI: 10.1038/s41467-023-39027-x.
MacLeod K
J Physiol. 2022; 601(5):905-921.
PMID: 35946572
PMC: 10952717.
DOI: 10.1113/JP283082.
Kheyfets V, Dufva M, Boehm M, Tian X, Qin X, Tabakh J
Physiol Rep. 2020; 8(9):e14347.
PMID: 32367677
PMC: 7198956.
DOI: 10.14814/phy2.14347.
B-type natriuretic peptide and its role in altering Ca-regulatory proteins in heart failure-mechanistic insights.
Zhao J, Xu T, Zhou Y, Zhou Y, Xia Y, Li D
Heart Fail Rev. 2019; 25(5):861-871.
PMID: 31820203
DOI: 10.1007/s10741-019-09883-1.
Current Landscape of Heart Failure Gene Therapy.
Kieserman J, Myers V, Dubey P, Cheung J, Feldman A
J Am Heart Assoc. 2019; 8(10):e012239.
PMID: 31070089
PMC: 6585330.
DOI: 10.1161/JAHA.119.012239.
Unique Ca-Cycling Protein Abundance and Regulation Sustains Local Ca Releases and Spontaneous Firing of Rabbit Sinoatrial Node Cells.
Vinogradova T, Sirenko S, Lakatta E
Int J Mol Sci. 2018; 19(8).
PMID: 30044420
PMC: 6121616.
DOI: 10.3390/ijms19082173.
Network-based predictions of in vivo cardiac hypertrophy.
Frank D, Sutcliffe M, Saucerman J
J Mol Cell Cardiol. 2018; 121:180-189.
PMID: 30030017
PMC: 6175293.
DOI: 10.1016/j.yjmcc.2018.07.243.
Oxidative profiling of the failing right heart in rats with pulmonary hypertension.
Wang X, Shults N, Suzuki Y
PLoS One. 2017; 12(5):e0176887.
PMID: 28472095
PMC: 5417519.
DOI: 10.1371/journal.pone.0176887.
Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression.
Byrne N, Levasseur J, Sung M, Masson G, Boisvenue J, Young M
Cardiovasc Res. 2016; 110(2):249-57.
PMID: 26968698
PMC: 4836630.
DOI: 10.1093/cvr/cvw051.
Atherosclerotic cardiovascular disease: a review of initiators and protective factors.
S Ellulu M, Patimah I, Khazaai H, Rahmat A, Abed Y, Ali F
Inflammopharmacology. 2016; 24(1):1-10.
PMID: 26750181
DOI: 10.1007/s10787-015-0255-y.
Apamin-Sensitive K+ Current Upregulation in Volume-Overload Heart Failure is Associated with the Decreased Interaction of CK2 with SK2.
Yang D, Wang T, Ni Y, Song B, Ning F, Hu P
J Membr Biol. 2015; 248(6):1181-9.
PMID: 26362340
DOI: 10.1007/s00232-015-9839-0.
Gαq protein carboxyl terminus imitation polypeptide GCIP-27 improves cardiac function in chronic heart failure rats.
Lu X, Tong Y, Liu Y, Xu Y, Yang H, Zhang G
PLoS One. 2015; 10(3):e0121007.
PMID: 25822412
PMC: 4379177.
DOI: 10.1371/journal.pone.0121007.
Stage-dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure.
Nonaka M, Morimoto S, Murayama T, Kurebayashi N, Li L, Wang Y
Br J Pharmacol. 2015; 172(9):2369-82.
PMID: 25560565
PMC: 4403100.
DOI: 10.1111/bph.13062.
Experimental models of inherited cardiomyopathy and its therapeutics.
Nonaka M, Morimoto S
World J Cardiol. 2014; 6(12):1245-51.
PMID: 25548614
PMC: 4278159.
DOI: 10.4330/wjc.v6.i12.1245.
POLRMT does not transcribe nuclear genes.
Kuhl I, Kukat C, Ruzzenente B, Milenkovic D, Mourier A, Miranda M
Nature. 2014; 514(7521):E7-11.
PMID: 25297440
DOI: 10.1038/nature13690.
Tropomyosin dephosphorylation results in compensated cardiac hypertrophy.
Schulz E, Correll R, Sheikh H, Lofrano-Alves M, Engel P, Newman G
J Biol Chem. 2012; 287(53):44478-89.
PMID: 23148217
PMC: 3531761.
DOI: 10.1074/jbc.M112.402040.
Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.
Kho C, Lee A, Hajjar R
Nat Rev Cardiol. 2012; 9(12):717-33.
PMID: 23090087
PMC: 3651893.
DOI: 10.1038/nrcardio.2012.145.
Ultrastructural remodelling of Ca(2+) signalling apparatus in failing heart cells.
Wu H, Xu M, Li R, Guo L, Lai Y, Xu S
Cardiovasc Res. 2012; 95(4):430-8.
PMID: 22707157
PMC: 3422078.
DOI: 10.1093/cvr/cvs195.
